Scan to Download ios&Android APP

Trade Verastem - VSTM CFD

1.24
5.08%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading Conditions
Long position overnight fee -0.0225%
Short position overnight fee -0.0219%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 20%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 1.18
Open* 1.2
Day's Range* 1.2 - 1.2
1-Year Change* -2.44%
Volume N/A
Average Vol. (3m) 37.4267
52 wk Range N/A
Market Cap 238.516
P/E Ratio N/A
Shares Outstanding 187808000
Revenue 3.143
EPS -0.43017
Dividend (Yield %) N/A
Beta 0.80647
Next Earnings Date Nov 2, 2022

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Aug 12, 2022 1.24 0.05 4.20% 1.19 1.24 1.19
Aug 11, 2022 1.18 -0.05 -4.07% 1.23 1.25 1.18
Aug 10, 2022 1.23 0.04 3.36% 1.19 1.25 1.19
Aug 9, 2022 1.19 -0.03 -2.46% 1.22 1.23 1.13
Aug 8, 2022 1.25 0.11 9.65% 1.14 1.27 1.14
Aug 5, 2022 1.18 0.08 7.27% 1.10 1.18 1.09
Aug 4, 2022 1.12 0.04 3.70% 1.08 1.12 1.08
Aug 3, 2022 1.09 0.04 3.81% 1.05 1.12 1.05
Aug 2, 2022 1.07 0.01 0.94% 1.06 1.08 1.04
Aug 1, 2022 1.05 0.01 0.96% 1.04 1.08 1.03
Jul 29, 2022 1.04 -0.05 -4.59% 1.09 1.09 1.03
Jul 28, 2022 1.09 -0.02 -1.80% 1.11 1.11 1.07
Jul 27, 2022 1.11 0.01 0.91% 1.10 1.12 1.09
Jul 26, 2022 1.09 -0.01 -0.91% 1.10 1.11 1.09
Jul 25, 2022 1.10 -0.04 -3.51% 1.14 1.15 1.10
Jul 22, 2022 1.15 -0.06 -4.96% 1.21 1.24 1.14
Jul 21, 2022 1.21 0.00 0.00% 1.21 1.22 1.19
Jul 20, 2022 1.22 0.03 2.52% 1.19 1.22 1.17
Jul 19, 2022 1.19 0.11 10.19% 1.08 1.19 1.08
Jul 18, 2022 1.09 0.00 0.00% 1.09 1.12 1.08

Verastem Events

Time (UTC) Country Event
Wednesday, November 2, 2022
10:59
  US
Q3 2022 Verastem Inc Earnings Release
View all events
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total revenue 0 0 26.718 17.456 88.516 2.053
Total Operating Expense 37.002 67.804 121.501 149.797 139.456 63.462
Selling/General/Admin. Expenses, Total 17.223 21.381 77.265 101.212 58.655 24.115
Research & Development 19.779 46.423 43.648 45.778 40.876 39.347
Operating Income -37.002 -67.804 -94.783 -132.341 -50.94 -61.409
Interest Income (Expense), Net Non-Operating 0.562 0.002 -3.207 -16.227 -15.279 -9.791
Net Income Before Taxes -36.44 -67.802 -72.434 -149.209 -67.532 -71.2
Net Income After Taxes -36.44 -67.802 -72.434 -149.209 -67.726 -71.2
Net Income Before Extra. Items -36.44 -67.802 -72.434 -149.209 -67.726 -71.2
Net Income -36.44 -67.802 -72.434 -149.209 -67.726 -71.2
Income Available to Common Excl. Extra. Items -36.44 -67.802 -72.434 -149.209 -67.726 -71.2
Income Available to Common Incl. Extra. Items -36.44 -67.802 -72.434 -149.209 -67.726 -71.2
Diluted Net Income -36.44 -67.802 -72.434 -149.209 -67.726 -71.2
Diluted Weighted Average Shares 36.988 38.422 64.962 74.578 153.33 174.406
Diluted EPS Excluding Extraordinary Items -0.98518 -1.76467 -1.11502 -2.00071 -0.4417 -0.40824
Diluted Normalized EPS -0.98518 -1.76467 -1.11502 -2.04362 -0.4155 -0.40801
Revenue 26.718 17.456 88.516 2.053
Cost of Revenue, Total 0.165 1.238 32.952 0
Gross Profit 26.553 16.218 55.564 2.053
Depreciation / Amortization 0.423 1.569 0.793 0
Other, Net 25.556 -0.641 -1.313 0
Unusual Expense (Income) 6.18 0
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Total revenue 1.006 0.5 0.002 0.545 2.596
Revenue 1.006 0.5 0.002 0.545 2.596
Cost of Revenue, Total 0 0 0 0
Gross Profit 1.006 0.5 0.002 0.545
Total Operating Expense 15.114 16.444 14.848 17.056 19.576
Selling/General/Admin. Expenses, Total 6.218 6.714 5.523 5.66 5.934
Research & Development 8.896 9.73 9.325 11.396 13.642
Depreciation / Amortization 0 0 0 0
Operating Income -14.108 -15.944 -14.846 -16.511 -16.98
Interest Income (Expense), Net Non-Operating -0.923 -0.958 -7.94 0.03 -0.01
Net Income Before Taxes -15.031 -16.902 -22.786 -16.481 -16.962
Net Income After Taxes -15.031 -16.902 -22.786 -16.481 -16.962
Net Income Before Extra. Items -15.031 -16.902 -22.786 -16.481 -16.962
Net Income -15.031 -16.902 -22.786 -16.481 -16.962
Income Available to Common Excl. Extra. Items -15.031 -16.902 -22.786 -16.481 -16.962
Income Available to Common Incl. Extra. Items -15.031 -16.902 -22.786 -16.481 -16.962
Diluted Net Income -15.031 -16.902 -22.786 -16.481 -16.962
Diluted Weighted Average Shares 171.586 171.985 179.861 174.052 186.264
Diluted EPS Excluding Extraordinary Items -0.0876 -0.09828 -0.12669 -0.09469 -0.09106
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.0876 -0.09828 -0.12646 -0.09469 -0.09106
Other, Net 0 0 0 0.028
Unusual Expense (Income) 0
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total Current Assets 81.295 87.787 253.259 84.961 144.938 105.74
Cash and Short Term Investments 80.897 86.672 249.653 75.506 141.226 100.256
Cash & Equivalents 32.349 82.176 129.867 43.514 67.782 21.252
Short Term Investments 48.548 4.496 119.786 31.992 73.444 79.004
Total Receivables, Net 0.204 0.306 2.524 0.239 0.516
Prepaid Expenses 0.194 1.115 2.973 3.835 3.473 4.968
Total Assets 83.629 89.791 277.236 145.046 154.349 108.662
Property/Plant/Equipment, Total - Net 1.417 0.861 1.369 4.024 3.142 2.512
Property/Plant/Equipment, Total - Gross 3.616 3.616 1.878 4.962 4.611 4.187
Accumulated Depreciation, Total -2.199 -2.755 -0.509 -0.938 -1.469 -1.675
Other Long Term Assets, Total 0.917 1.143 1.031 36.053 0.274 0.41
Total Current Liabilities 10.991 17.128 37.077 29.89 17.093 18.59
Accounts Payable 4.095 9.186 10.253 9.655 1.875 2.302
Accrued Expenses 6.721 7.752 21.108 19.785 15.218 16.288
Notes Payable/Short Term Debt 0 0 0 0 0 0
Other Current Liabilities, Total 0.175 0.19 0.45 0
Total Liabilities 11.332 32.107 152.937 137.872 39.075 21.103
Total Long Term Debt 0 14.828 114.737 103.623 19.051 0.249
Other Liabilities, Total 0.341 0.151 1.123 4.359 2.931 2.264
Total Equity 72.297 57.684 124.299 7.174 115.274 87.559
Common Stock 0.004 0.005 0.007 0.008 0.017 0.019
Additional Paid-In Capital 307.587 360.823 499.741 531.937 707.715 751.217
Retained Earnings (Accumulated Deficit) -235.323 -303.142 -375.576 -524.785 -592.511 -663.711
Other Equity, Total 0.029 -0.002 0.127 0.014 0.053 0.034
Total Liabilities & Shareholders’ Equity 83.629 89.791 277.236 145.046 154.349 108.662
Total Common Shares Outstanding 36.992 50.801 73.806 80.118 170.456 185.286
Long Term Debt 14.828 114.737 103.623 19.051 0.249
Accounts Receivable - Trade, Net 0.306 2.524 0.239 0.516
Total Inventory 0.327 3.096 0
Intangibles, Net 21.577 20.008 0
Current Port. of LT Debt/Capital Leases 5.716 0
Long Term Investments 5.995 0
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Total Current Assets 127.678 114.76 108.757 105.74 113.439
Cash and Short Term Investments 121.097 108.135 103.416 100.256 106.278
Cash & Equivalents 35.514 24.972 24.314 21.252 46.687
Short Term Investments 85.583 83.163 79.102 79.004 59.591
Total Receivables, Net 1.125 0.476 0.105 0.516 2.644
Accounts Receivable - Trade, Net 1.125 0.476 0.105 0.516 2.644
Prepaid Expenses 5.456 6.149 5.236 4.968 4.517
Total Assets 136.901 123.89 111.877 108.662 116.148
Property/Plant/Equipment, Total - Net 2.963 2.794 2.656 2.512 2.363
Long Term Investments 5.998 5.992 0 0
Other Long Term Assets, Total 0.262 0.344 0.464 0.41 0.346
Total Current Liabilities 11.844 12.744 13.536 18.59 16.886
Accounts Payable 2.453 1.395 0.641 2.302 2.896
Accrued Expenses 9.391 11.349 12.895 16.288 13.99
Notes Payable/Short Term Debt 0 0 0 0 0
Total Liabilities 34.292 35.685 16.222 21.103 43.377
Total Long Term Debt 19.672 20.326 0.243 0.249 24.412
Long Term Debt 19.672 20.326 0.243 0.249 24.412
Other Liabilities, Total 2.776 2.615 2.443 2.264 2.079
Total Equity 102.609 88.205 95.655 87.559 72.771
Common Stock 0.017 0.017 0.018 0.019 0.019
Additional Paid-In Capital 710.1 712.593 742.84 751.217 753.538
Retained Earnings (Accumulated Deficit) -607.542 -624.444 -647.23 -663.711 -680.673
Other Equity, Total 0.034 0.039 0.027 0.034 -0.113
Total Liabilities & Shareholders’ Equity 136.901 123.89 111.877 108.662 116.148
Total Common Shares Outstanding 171.731 172.077 182.155 185.286 186.33
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Net income/Starting Line -36.44 -67.802 -72.434 -149.209 -67.726 -71.2
Cash From Operating Activities -29.484 -57.31 -74.515 -138.518 -33.506 -53.502
Cash From Operating Activities 0.67 0.556 0.996 0.429 0.531 0.206
Non-Cash Items 6.147 5.256 -17.15 16.492 21.261 16.908
Cash Interest Paid 0 0.295 2.107 12.424 5.126 1.007
Changes in Working Capital 0.139 4.68 13.65 -7.799 11.635 0.584
Cash From Investing Activities 36.927 43.953 -138.377 89.613 -47.363 0.087
Capital Expenditures -0.039 0 -23.507 -0.007 -0.033 -0.196
Other Investing Cash Flow Items, Total 36.966 43.953 -114.87 89.62 -47.33 0.283
Cash From Financing Activities -0.005 63.184 261.162 -2.441 69.63 6.885
Financing Cash Flow Items -0.005 -0.138 -0.506 -2.048 -0.925
Issuance (Retirement) of Stock, Net 0 48.511 105.965 0.569 109.044 7.81
Issuance (Retirement) of Debt, Net 0 14.811 155.197 -2.504 -37.366 0
Net Change in Cash 7.438 49.827 48.27 -51.346 -11.239 -46.53
Amortization 0.423 1.569 0.793 0
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Net income/Starting Line -15.031 -31.933 -54.719 -71.2 -16.962
Cash From Operating Activities -19.318 -32.742 -43.569 -53.502 -19.281
Cash From Operating Activities 0.081 0.146 0.176 0.206 0.03
Non-Cash Items 2.584 5.416 15.326 16.908 1.626
Cash Interest Paid 0 0 0 0
Changes in Working Capital -6.952 -6.371 -4.352 0.584 -3.975
Cash From Investing Activities -12.372 -9.979 0.021 0.087 19.264
Capital Expenditures -0.196 -0.196 -0.196 -0.196 0
Other Investing Cash Flow Items, Total -12.176 -9.783 0.217 0.283 19.264
Cash From Financing Activities -0.578 -0.089 0.08 6.885 25.452
Financing Cash Flow Items -0.878 -0.907 -0.999 -0.925 0
Issuance (Retirement) of Stock, Net 0.3 0.818 1.079 7.81 0.68
Net Change in Cash -32.268 -42.81 -43.468 -46.53 25.435
Amortization 0 0 0
Issuance (Retirement) of Debt, Net 0 24.772

Why choose Capital.com? Our numbers speak for themselves.

Capital.com Group
427000+

Traders

71000+

Active clients monthly

$46000000+

Monthly investing volume

$17000000+

Withdrawn each month

Verastem Company profile

Verastem
Industry: Bio Therapeutic Drugs

117 Kendrick St Ste 500
CAMBRIDGE
MASSACHUSETTS 02142
US

Income statement

People Also Watch

Ripple to US Dollar

0.37 Price
-2.570% 1D Chg, %
Long position overnight fee -0.0500%
Short position overnight fee 0.0140%
Overnight fee time 21:00 (UTC)
Spread 0.00600

Still looking for a broker you can trust?

Join the 427.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading